Skip to main content

Table 4 Univariate analysis for re-stenosis

From: Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement

Variables

Hazard ratio (95% CI)

P value

Age

1.043 (0.906–1.083)

0.091

Male

1.052 (0.922–1.074)

0.106

Smoking

1.078 (1.003–1.125)

0.015

HTN

1.106 (1.018–1.276)

0.021

DM

1.145 (1.056–1.303)

0.007

Family history

1.008 (0.914–1.022)

0.108

BMI

1.002 (0.967–1.005)

0.455

CHOL

1.089 (0.953–1.117)

0.075

LDL-C

1.227 (1.104–1.420)

<0.001

HDL-C

0.895 (0.806–1.007)

0.303

TG

1.007 (0.926–1.011)

0.436

Lp (a)

1.103 (1.048–1.166)

0.014

CREA

1.012 (0.915–1.017)

0.344

BUN

1.005 (0.933–1.009)

0.428

Uric acid

1.017 (0.908–1.032)

0.447

Hs-CRP

1.168 (1.109–1.254)

<0.001

Lp-PLA2

1.233 (1.114–1.387)

<0.001

LVEF

1.017 (0.908–1.032)

0.160

FS

1.011 (0.933–1.019)

0.174

Anti-platelet

0.826 (0.801–0.944)

0.022

Statins

0.778 (0.723–0.806)

<0.001

Medications for HTN

0.909 (0.886–1.005)

0.096

Medications for DM

0.845 (0.817–0.896)

0.018

  1. Denote: CI = confidence interval.